Cargando…
Elevation of enterococcus-specific antibodies associated with bacterial translocation is predictive of survival rate in chronic liver disease
INTRODUCTION/PURPOSE: The gut-liver axis contributes to disease progression, a rise in infection rate, organ failure and a poor overall outcome in chronic liver diseases (CLD). Monitoring of the gut-liver axis is critical in understanding disease status, but biomarkers have not been elucidated. The...
Autores principales: | Iwasa, Motoh, Eguchi, Akiko, Tamai, Yasuyuki, Shigefuku, Ryuta, Nakagawa, Ryo, Hasegawa, Hiroshi, Kondo, Jumpei, Morikawa, Masayuki, Miyoshi, Eiji, Nakagawa, Hayato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403143/ https://www.ncbi.nlm.nih.gov/pubmed/36035413 http://dx.doi.org/10.3389/fmed.2022.982128 |
Ejemplares similares
-
Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021) -
Association of lithocholic acid with skeletal muscle hypertrophy through TGR5-IGF-1 and skeletal muscle mass in cultured mouse myotubes, chronic liver disease rats and humans
por: Tamai, Yasuyuki, et al.
Publicado: (2022) -
Update on blood‐based biomarkers for chronic liver diseases prognosis: Literature review and institutional experience
por: Iwasa, Motoh, et al.
Publicado: (2021) -
Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
por: Tamai, Yasuyuki, et al.
Publicado: (2020) -
Effect of pemafibrate on liver enzymes and shear wave velocity in non-alcoholic fatty liver disease patients
por: Sugimoto, Ryosuke, et al.
Publicado: (2023)